Dr. Fredric Siskron

Dr. Fredric Siskron
Dr. Siskron is a native of Shreveport and a graduate of Centenary College of Louisiana and LSU-Shreveport School of Medicine. He completed an internship in General Surgery in Shreveport and was then called to complete his service in the United States Air Force as a General Medical Officer, stationed at Hill AFB in Salt Lake City, UT. He then returned to Shreveport to complete his residency in Urology at LSUHSC Shreveport, where he served as chief resident in 2006. Preferring the traditional, smaller practice setting to the larger group model that was becoming more common in all specialties at the time, Dr. Siskron founded Signature Urology at Willis-Knighton Medical Center in July of 2006, and has practiced in this location ever since. He is board certified by the American Board of Urology, and provides a broad range of general Urology services to the patients of Willis-Knighton and the broader community. He is a board member of the Shreveport Medical Society and is a member of the American Urological Association. He has many hobbies outside of his practice, but is especially passionate about maintaining a healthy lifestyle and exercising regularly (the benefits of which, he also tries to relay to his patients), spending time with family, traveling, and outdoor activities of all kinds.
Medical School:

Louisiana State University School of Medicine (1997)

Residency:

LSUHSC Shreveport School of Medicine (2006)

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only